Nissen, Michael D <br/><br/>
A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents.  [electronic resource] 

 -  The Pediatric infectious disease journal  Apr 2013 
 - 364-71 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-0987 
<br/><br/><label>Standard No.: </label>10.1097/INF.0b013e31827b0d24  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antigens, Bacterial--genetics<br/>Australia<br/>Bacterial Proteins--genetics<br/>Blood Bactericidal Activity<br/>Child<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Female<br/>Humans<br/>Male<br/>Meningococcal Infections--immunology<br/>Meningococcal Vaccines--administration & dosage<br/>Neisseria meningitidis, Serogroup B--genetics<br/>Recombinant Proteins--genetics<br/>Single-Blind Method<br/>Vaccines, Synthetic--administration & dosage